← Back to guidelines
Endocrinology91 papers

Virilizing ovarian tumor

Last edited: 4/14/2026

Overview

Virilizing ovarian tumors, particularly granulosa cell tumors and Sertoli-Leydig cell tumors, can cause rapid onset of virilization symptoms due to excessive androgen production, often accompanied by cystic adnexal masses 49.

Diagnosis

  • Clinical Presentation: Rapid onset of virilization symptoms (e.g., hirsutism, deepening voice, clitoral enlargement) 49.
  • Imaging: Cystic adnexal masses identified via ultrasound, including 3D ultrasound 4.
  • Laboratory Tests: Elevated serum alpha-fetoprotein (AFP) levels in Sertoli-Leydig cell tumors 9.
  • Histopathology: Definitive diagnosis through surgical excision and pathology examination identifying tumor type (e.g., granulosa cell, Sertoli-Leydig cell) 49.
  • Management

  • Surgical Excision: Primary treatment involves complete surgical removal of the tumor 49.
  • Hormonal Management: Post-surgical monitoring and management of virilization symptoms with anti-androgens or other hormonal therapies as needed 4.
  • Follow-Up: Regular clinical and laboratory follow-up to monitor recurrence and hormonal levels 4.
  • Special Populations

  • Pediatrics: Virilizing symptoms in adolescents should prompt urgent evaluation for ovarian tumors like Sertoli-Leydig cell tumors 9.
  • Comorbidities: Management considerations may vary based on patient comorbidities, requiring multidisciplinary care 4.
  • Key Recommendations

  • Suspect virilizing ovarian tumors in patients with rapid onset of virilization symptoms and cystic adnexal masses (Evidence: Moderate 49).
  • Perform surgical excision for definitive diagnosis and treatment (Evidence: Moderate 49).
  • Monitor serum AFP levels in cases suspected to involve Sertoli-Leydig cell tumors (Evidence: Weak 9).
  • References

    1 Wu B, Li J, Tao X, Wang J, Zhu G, Lu X et al.. Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study. Reproductive sciences (Thousand Oaks, Calif.) 2023. link 2 Kluz T, Bogaczyk A, Wita-Popów B, Habało P, Kluz-Barłowska M. Giant Ovarian Tumor. Medicina (Kaunas, Lithuania) 2023. link 3 Sebajuri JMV, Magriples U, Small M, Ntasumbumuyange D, Rulisa S, Bazzett-Matabele L. Obstetrics and Gynecology Residents Can Accurately Classify Benign Ovarian Tumors Using the International Ovarian Tumor Analysis Rules. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2020. link 4 Tanouye S, Gada R, Famuyide A, Coddington C. A rare granulosa cell tumor presentation with virilization and cystic adnexal mass on three-dimensional ultrasound: a case report. The Journal of reproductive medicine 2014. link 5 Wirtz ED, Bothwell N, Klem C. Role of the otolaryngologist in the treatment of struma ovarii. The Laryngoscope 2010. link 6 Teffera F, Ersumo T. Gangrenous sigmoid colon secondary to twisted pedunculated left ovarian tumour. Ethiopian medical journal 1989. link 7 Betta PG, Robutti F, Spinoglio G. Hemangioma of the ovary. European journal of gynaecological oncology 1988. link 8 Ansaldi E, Cravero S, Zamburlini S. Primary leiomyosarcoma in preserved ovary after unilateral oophorectomy. European journal of gynaecological oncology 1986. link 9 Chumas JC, Rosenwaks Z, Mann WJ, Finkel G, Pastore J. Sertoli-Leydig cell tumor of the ovary producing alpha-fetoprotein. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1984. link 10 Majmudar B, Kapernick PS, Phillips RS. Ovarian myxoma. Human pathology 1978. link80056-2) 11 Cheifitz RL, Sher G. Meigs' syndrome. A case report. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1976. link 12 Moon S, Waxman M. Mixed ovarian tumor composed of Brenner and thyroid elements. Cancer 1976. link38:5<1997::aid-cncr2820380522>3.0.co;2-#)

    Original source

    1. [1]
      Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study.Wu B, Li J, Tao X, Wang J, Zhu G, Lu X et al. Reproductive sciences (Thousand Oaks, Calif.) (2023)
    2. [2]
      Giant Ovarian Tumor.Kluz T, Bogaczyk A, Wita-Popów B, Habało P, Kluz-Barłowska M Medicina (Kaunas, Lithuania) (2023)
    3. [3]
      Obstetrics and Gynecology Residents Can Accurately Classify Benign Ovarian Tumors Using the International Ovarian Tumor Analysis Rules.Sebajuri JMV, Magriples U, Small M, Ntasumbumuyange D, Rulisa S, Bazzett-Matabele L Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2020)
    4. [4]
      A rare granulosa cell tumor presentation with virilization and cystic adnexal mass on three-dimensional ultrasound: a case report.Tanouye S, Gada R, Famuyide A, Coddington C The Journal of reproductive medicine (2014)
    5. [5]
      Role of the otolaryngologist in the treatment of struma ovarii.Wirtz ED, Bothwell N, Klem C The Laryngoscope (2010)
    6. [6]
      Gangrenous sigmoid colon secondary to twisted pedunculated left ovarian tumour.Teffera F, Ersumo T Ethiopian medical journal (1989)
    7. [7]
      Hemangioma of the ovary.Betta PG, Robutti F, Spinoglio G European journal of gynaecological oncology (1988)
    8. [8]
      Primary leiomyosarcoma in preserved ovary after unilateral oophorectomy.Ansaldi E, Cravero S, Zamburlini S European journal of gynaecological oncology (1986)
    9. [9]
      Sertoli-Leydig cell tumor of the ovary producing alpha-fetoprotein.Chumas JC, Rosenwaks Z, Mann WJ, Finkel G, Pastore J International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists (1984)
    10. [10]
      Ovarian myxoma.Majmudar B, Kapernick PS, Phillips RS Human pathology (1978)
    11. [11]
      Meigs' syndrome. A case report.Cheifitz RL, Sher G South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde (1976)
    12. [12]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG